12. International Symposium of Gastroenterology

Дата

с 24.05.2018 по 26.05.2018

Место

Словацкая Республика, Братислава

Регистрационный взнос

€360

Темы

Metabolic syndrome and NAFLD; Metabolic (bariatric) surgery; Hepatology; The microbiome; Gastrointestinal tract and motility disorders; Varia

Программа

Session I: Metabolic syndrome

Current and future landscape of NASH

Diagnostic algoritm for NAFLD and NASH in clinical practice

Therapy of NAFLD 1: An overview of nonpharmacological modalities

Therapy of NAFLD 2: Pharmacotherapy - metabolic role of UDCA and other bile acids

Diabesity, and cardiovascular risk: How to manage them in patients with NAFLD - an approach for everyday practice

Session II: Metabolic (bariatric) surgery

Effect of metabolic and bariatric surgery in patients with NAFLD/NASH

Effect of bariatric surgery in patients with T2DM

Methodology showing different effects of individual techniques

Targeting the gastrointestinal tract in the treatment of obesity/type 2 diabetes and Q of place for bile acids

Session III: The microbiome

Gut microbiome and cholestatic liver diseases

Fecal microbiota transplantation as a novel treatment of digestive diseases

Microbiome dysbiosis and hepatocellular carcinoma

SIBO and other gastrointestinal diseases: What is the connection

Session IV: Hepatology

Hepatitis C: An update

Epidemiology of cholestatic liver diseases

PSC and UC: The role of UDCA

Hepatoprotective role of ursodeoxycholic acid (UDCA)

Portal vein thrombosis (cirrhotic and non-cirrhotic)

Session V: Gastrointestinal tract and motility disorders

GERD: Beyond the acid

The risks and benefits of long-term use of proton pump inhibitors

Gastrointestinal motility disorders in Type 2 Diabetes Mellitus

Obesity and gastroesofageal reflux disease

Why the Non-standard approaches to H. pylori eradication are needed?

Session VI: Varia

Intestinal fibrosis in IBD. Do we have a chance to solve it?

Prevention of acute pancreatitis

Cholestasis and IBD in pregnancy

Predictive factors for the effectiveness of primary biliary cholangitis treatment

Alcoholic hepatitis - an update

ISG 2018